Y-3 Injection Through Skull Bone Marrow in the Treatment of Acute Malignant Middle Cerebral Artery Infarction (SOLUTION)
Clinical trial NCT05849805 · COMPLETED
Trial details
- NCT number
- NCT05849805
- Sponsor
- Beijing Tiantan Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-17
- Primary completion
- 2023-11-06
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.